Fritextsökning
Artiklar per år
Innehållstyper
-
High-tech companies are increasingly focusing on health
Tech companies have been taking an interest in healthcare for many years, and this interest seems to be increasing. “It’s not a sudden shift in trend, it’s more about them advancing their positions,” says Anna Lefevre Skjöldebrand, CEO of Swedish Medtech.
-
The physician at the tech giant: “Observations in the emergency room made my mind up”
When Nasim Farrokhnia was in third grade at school in Tehran, the capital of Iran, her father gave her a book about Marie Curie, which soon became her favourite book. Perhaps her interest in science was born there and then, as science and new technology have since been a constant feature of her working life. Today, she is a Healthcare Manager in Microsoft’s Western Europe team.
-
Study names with an attitude – more important than you might think
Ironman, T-rex, Star-Trek. Popcorn, Proper, Scout. Nope, these are neither fantasy films nor dog names. They’re the names of ongoing cancer studies in Sweden.
-
The first drugs to slow down Alzheimer’s – but what does it mean for patients?
New treatments for early Alzheimer’s are bringing hope to thousands of patients and their families. The question is, who will get the treatment, how will the right patients be found in time, and will the healthcare system’s resources be sufficient? Life Science Sweden has spoken to Swedish researchers in Alzheimer’s who voice cautious hope but also see further challenges.
-
Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”
It all started with a summer job as an operator at Astra’s chemical factory in Snäckviken, just outside Södertälje. More than three decades and countless different assignments later, Per Alfredsson, born and raised in Södertälje, is CEO of Astra Zeneca Sweden, which employs 7800 people in Södertälje, Stockholm and Gothenburg. “It was a very special feeling to be in charge of the entire organisation,” he says in an interview about his career and potential future blockbusters.
-
19 medicines in Sweden are under investigation in a major EMA inquiry
19 medicines marketed in Sweden are affected by an ongoing extensive European investigation into suspected fraud at an Indian contract research organisation. Among them are medicines for HIV, epilepsy, cancer and Parkinson’s, which may be withdrawn
-
Samuel Lagercrantz: A special kind of hellishness afflicts post-COVID patients
In addition to the disease itself those suffering from post-COVID have to deal with people who try to label them as hypochondriacs, writes Samuel Lagercrantz in an editorial.
-
Studie: Musiklyssnande celler frigjorde insulin hos rockande möss
Kan celler designade för att producera insulin och en gammal rockdänga vara receptet på en behandling av diabetes? Det är något forskare i Schweiz tittat närmare på.
-
Double up for Korbinian Löbmann
This year, Korbinian Löbmann will moderate the New Updates in Drug Formulation & Bioavailability meeting in Copenhagen for the fifth time. Furthermore, he will also moderate The Future of Swedish & Danish Life Science congress in Lund for the first time.
-
Why the world renown researcher Marc Tessier-Lavigne resigns as Stanford´s president
In mid-summer, neuroscientist Marc Tessier-Lavigne announced his resignation as President of Stanford following allegations of manipulated study data. According to the reporter Theo Baker, who first reported the story, Tessier-Lavigne “rewarded the winners and punished the losers”. Here is the background of the story which has shaken the American scientific community over the summer.
-
Första pillret mot förlossningsdepression godkänt i USA
Den första orala behandlingen specifikt inriktad på förlossningsdepression har godkänts av FDA.
-
Neanderthal gene variants may cause Viking disease
A new study suggests that the so-called Viking disease, which affects the hand function in many older people, may be linked to gene variants inherited from Neanderthals.
-
Rapid developments in AI – “All stakeholders are struggling to understand it”
Artificial intelligence is being discussed more and more, and developments in the field are moving rapidly. As the Swedish Medical Products Agency testifies, keeping up with developments is not easy.
-
Swedish and Ukrainian Medical Product Agencies sign an agreement
The Directors-General of the Swedish and Ukrainian Medical Products Agencies have signed a cooperation agreement.
-
Study: Chat GPT is more empathetic than doctors
The AI tool Chat GPT is not only more accurate when it comes to answering patient questions – the chatbot is also perceived as almost 10 times more empathetic than real doctors, a new study reveals.
-
Antikroppar tog form med hjälp av artificiell intelligens
Språkmodeller, såsom Chat GPT, som bygger på artificiell intelligens kan användas till en rad olika saker. Nu har forskare, med en språkmodell tillverkad av ett välkänt amerikanskt företag, i en ny studie kunnat designa antikroppar, rapporterar Nature.
-
Confidence in childhood vaccines is in decline worldwide
Since the pandemic, confidence in vaccinating children has plummeted. In a new report, UNICEF urges world leaders to act before the situation worsens. In 52 out of 55 countries surveyed, public perception of the importance of vaccinating children has declined.
-
Alligators aktie upp kraftigt efter delårsrapport
Immunterapibolaget Alligator Bioscience steg kraftigt på börsen på tisdagen efter en delårsrapport där bolaget uttrycker optimism om en accelererad utveckling för sin läkemedelskandidat mitazalimab mot bukspottkörtelcancer.
-
He got inside the head of Sweden’s vaccine hunter
The hunt for the COVID-19 vaccine is the theme of the new book Vaccinjägaren (The Vaccine Hunter). It tells the story of Richard Bergström’s mission as Sweden’s national vaccine coordinator and the scheming that went on behind the scenes in Europe
-
The impact of the recession on the Swedish medtech sector
We need health care regardless of whether the economy is good or bad, but the current recession also affects the Medtech sector.
-
Läkemedelsdesign till nya höjder – med Elon Musks rymdsond
Kan tyngdlöshet öppna för nya och bättre sätt att designa läkemedel? Frågan ställs av Bristol Myers Squibb och svaret hoppas man hitta på en plats dit få läkemedel färdats: yttre rymden.
-
Vinnova is going to establish a new innovation cluster
Vinnova, the Swedish Agency for Innovation Systems, has been commissioned by the government to establish a national innovation cluster for advanced medicines.
-
Meeting with focus on South Korea and Japan’s life sciences
Large, complex and exciting – this is how Britta Stenson, Business Sweden, describes the life science markets of Japan and South Korea, which took centre stage during a webcast seminar.
-
Tuberkulosbakterier ska svältas ut - ny substans prövas på människa
Det amerikanska forskningsföretaget Calibr planerar att under ett år genomföra en klinisk studie med ett nytt sorts läkemedels mot tuberkulos.
BREAKING